His Eyeness Ophthalmics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.39 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
- Revenue Growth 71.96%
- Profit Growth 42.81%
- Ebitda -9.71%
- Net Worth 26.42%
- Total Assets 67.43%
About His Eyeness Ophthalmics
His Eyeness Ophthalmics Private Limited (HEOPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 August 2017 (Seven years and six months 9 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.39 M.
The company currently has active open charges totaling ₹4.00 Cr.
Suryanarayanan Krishnan, Bisi Reddy, Kavita Rautela, and One other member serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2017PTC105394
-
Company No.
105394
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Aug 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at His Eyeness Ophthalmics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bisi Reddy
|
Director | 08-Aug-2017 | Current |
|
Suryanarayanan Krishnan
|
Director | 08-Aug-2017 | Current |
|
Kavita Rautela
|
Director | 08-Aug-2017 | Current |
|
Muzammil Mohammad
|
Director | 08-Aug-2017 | Current |
Financial Performance of His Eyeness Ophthalmics.
His Eyeness Ophthalmics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.96% increase. The company also saw a substantial improvement in profitability, with a 42.81% increase in profit. The company's net worth Soared by an impressive increase of 26.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of His Eyeness Ophthalmics?
In 2023, His Eyeness Ophthalmics had a public holding of 57.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2022 | Hdfc Bank Limited | ₹4.00 Cr | Open |
How Many Employees Work at His Eyeness Ophthalmics?
His Eyeness Ophthalmics has a workforce of 90 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of His Eyeness Ophthalmics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped His Eyeness Ophthalmics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
